Melbourne, Victoria, Australia The high activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the The Jagen Group, startups are often financed by Data Collective DCVC, Capitol Health Ltd, Amplify Partners. The meaningful sponsors for the fund in investment in the same round are Thorney Investment, Regal Funds Management, Marubeni Corporation. In the next rounds fund is usually obtained by Fidelity Management and Research Company, Celgene, ARCH Venture Partners.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Nohla Therapeutics.
Related Funds
| Fund Name | Location |
| Allplan | Bayern, Germany, Munich |
| ChimeraBio | Dundee, Dundee City, United Kingdom |
| China Resources | China, Hong Kong, Hong Kong Island |
| Discover PreAccelerator | Lusaka, Lusaka, Zambia |
| Front Row Fund | Newtown, Pennsylvania, United States |
| Frontier Growth | Charlotte, North Carolina, United States |
| Future Planet Capital | England, London, United Kingdom |
| Hexcel Corporation | Connecticut, Stamford, United States |
| IMG Worldwide | New York, New York, United States |
| Innova-Tech Consulting | - |
| KOEI TECMO HOLDINGS | Japan, Kanagawa Prefecture, Yokohama |
| Kroger | Cincinnati, Ohio, United States |
| Lingshi Touzi | China, Guangdong, Shenzhen |
| Manipal Hospitals | Bangalore, India, Karnataka |
| Peppermint Holding | Berlin, Berlin, Germany |
| Serve Credit Union | Des Moines, Iowa, United States |
| T-street Capital | Connecticut, Darien, United States |
| Telecom Infra Project | California, Menlo Park, United States |
| Xiaomai | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Steppen | $1M | 27 Oct 2022 | - | ||
Enlitic | $25M | 14 Nov 2019 | San Francisco, California, United States | ||
Nohla Therapeutics | $43M | 30 Nov 2016 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Steppen | $1M | 27 Oct 2022 | - | ||
Enlitic | $25M | 14 Nov 2019 | San Francisco, California, United States | ||
Nohla Therapeutics | $43M | 30 Nov 2016 | Seattle, Washington, United States |
